UCB up after deal to sell unit to Cytec for \$1.86 bln LONDON (CBS.MW) -- Belgian pharmaceutical UCB rose 1.2 percent in mid-morning trade after the group agreed to sell its Surface Specialties business to Cytec Industries (CYT) for 1.5 billion euros (\$1.